Management of venous and cardiovascular thrombosis: enoxaparin.
Enoxaparin has strong clinical evidence that supports its license in a broad spectrum of therapeutic indications, including thromboprophylaxis in surgical patients, medical patients bedridden because of acute illness, the once-daily treatment of venous thromboembolism and the treatment of unstable angina and non-Q wave myocardial infarction.
Harvey
D M
DM
Department of Haematology, Northwick Park Hospital NHS Trust, Harrow, Middlesex.
Offord
R H
RH
D000789:Angina, Unstable / Q000188:drug therapy; D000925:Anticoagulants / Q000627:therapeutic use*; D003328:Coronary Thrombosis / Q000188:drug therapy*; D017984:Enoxaparin / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy; D011183:Postoperative Complications / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D020246:Venous Thrombosis / Q000188:drug therapy*
D000925:Anticoagulants; D017984:Enoxaparin; D005343:Fibrinolytic Agents